WO2013025763A3 - Tissue engineering using injectable, oxidized alginate hydrogels - Google Patents

Tissue engineering using injectable, oxidized alginate hydrogels

Info

Publication number
WO2013025763A3
WO2013025763A3 PCT/US2012/050876 US2012050876W WO2013025763A3 WO 2013025763 A3 WO2013025763 A3 WO 2013025763A3 US 2012050876 W US2012050876 W US 2012050876W WO 2013025763 A3 WO2013025763 A3 WO 2013025763A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
injectable
tissue engineering
alginate hydrogels
oxidized alginate
oxidized
Prior art date
Application number
PCT/US2012/050876
Other languages
French (fr)
Other versions
WO2013025763A2 (en )
Inventor
David J. Mooney
Woo Seob KIM
Original Assignee
President And Fellows Of Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/74Alginate

Abstract

Disclosed herein is a cell implantation pre-matrix composition comprising oxidized high molecular weight alginate and oxidized low molecular weight alginate, for combination with cells and polymerization into a hydrogel. Also disclosed are methods of generating a tissue at a site in a subject by the administration of the hydrogel described herein. The generation of fat tissue in a subject by the methods described herein is envisioned.
PCT/US2012/050876 2011-08-15 2012-08-15 Tissue engineering using injectable, oxidized alginate hydrogels WO2013025763A3 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US201161523506 true 2011-08-15 2011-08-15
US61/523,506 2011-08-15
US201161549012 true 2011-10-19 2011-10-19
US61/549,012 2011-10-19

Publications (2)

Publication Number Publication Date
WO2013025763A2 true WO2013025763A2 (en) 2013-02-21
WO2013025763A3 true true WO2013025763A3 (en) 2013-05-10

Family

ID=47715676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/050876 WO2013025763A3 (en) 2011-08-15 2012-08-15 Tissue engineering using injectable, oxidized alginate hydrogels

Country Status (1)

Country Link
WO (1) WO2013025763A3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554300A (en) * 2013-11-20 2014-02-05 青岛明月海藻集团有限公司 Method for preparing high-viscosity oxidized sodium alginate
WO2017165490A8 (en) * 2016-03-22 2017-10-19 President And Fellows Of Harvard College Biocompatible adhesives and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085295A1 (en) * 2006-07-14 2008-04-10 Fmc Biopolymer As Hydrogels containing low molecular weight alginates and biostructures made therefrom
EP0927196B1 (en) * 1996-09-19 2008-11-05 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0927196B1 (en) * 1996-09-19 2008-11-05 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates
US20080085295A1 (en) * 2006-07-14 2008-04-10 Fmc Biopolymer As Hydrogels containing low molecular weight alginates and biostructures made therefrom

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAO, X. ET AL.: 'Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction' CARDIOVASCULAR RESEARCH vol. 75, 2007, pages 178 - 185 *
KONG, H. J. ET AL.: 'Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype' PNAS vol. 103, 2006, pages 18534 - 18539 *

Also Published As

Publication number Publication date Type
WO2013025763A2 (en) 2013-02-21 application

Similar Documents

Publication Publication Date Title
WO2013012476A3 (en) Branched polyether-polyamide block copolymers and methods of making and using the same
WO2012006377A3 (en) Methods of raising an immune response by delivery of rna
WO2013030807A3 (en) Method and system for tissue modulation
WO2012019122A3 (en) Simplified basic media for human pluripotent cell culture
WO2008051568A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
WO2014179629A3 (en) Compositions and methods
WO2009100280A3 (en) 3-dimensional silk hydroxyapatite compositions
USD821318S1 (en) Rotor for a wave energy converter
Bolshakova et al. Tables of cross-sections of large-angle hadron production in proton-and pion-nucleus interactions III: tantalum nuclei and beam momenta from+/-3 GeV/c to+/-15 GeV/c
Nagler Dalteparin sodium/enoxaparin sodium/nadroparin calcium
Kaewniyompanit Methods for planning PV system installation in an urban energy system under constraints of PV output power variation
Yukihara et al. Development of Low Carbon Economy in China
نجاة سالم الشفتري et al. Energy Levels and Transition Probabilities Calculations ForK84-90 and Hg194-200Isotopes by Using the IBM-2
Unal Hybrid Living Space in the Context of Balat, Istanbul
Jayashree Prevalence of Obesity and Body Fat Composition Characteristics of Obese Children in Dharwad Taluk
応小宇 Design methods of the most suitable building layout based on wind environment simulation in consideration of summer and winter zone: for the case of large or middle scale projects
岡田睦実 et al. The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4 [+] T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans
Kirina Peculiarities of interaction of the pedagogue with students that have deviation in development
Teng et al. The Discussion of Environment and Health Work in Heilongjiang Province
Барский Shepherd MB Daniel in the context of the Hebrew Bible. NY; et al.: Peter Lang, 2009. XI, 163 p
Macnaughton Meanwhile: San Francisco's Farmers' Market Farmers in Their Own Words
Huang et al. Corrigendum to “Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL”
Lukina et al. The restoration of phytodiversity on the ash dump in the Ural
Bhatnagar et al. Cell Migration on crosslinked gelatin based scaffolds
Maurer The Subgroups of S6 in Cycle Form

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12824059

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 12824059

Country of ref document: EP

Kind code of ref document: A2